Post by Eye2Gene

We're proud to announce that Eye2Gene won 1st place at the final pitch event of the Amplify Venture Programme last Wednesday. 🎉 Our CTO, Ismail Moghul, took the stage to present Eye2Gene alongside an impressive cohort of startups, including ComplyLens, LendoCare, Period Harmony, iCook, Naxxar Technology, ASCENDIA TECH, and Date Sultan. At Eye2Gene, we’re building an AI-powered precision ophthalmology platform that combines imaging and genomics to accelerate diagnosis and therapy development for genetic eye diseases. Our platform enables biotech and pharmaceutical companies, as well as eyecare professionals, to make data-driven decisions that bring sight-saving treatments to patients earlier. By integrating retinal imaging with genomic analysis, we aim to reduce the diagnostic odyssey patients face from an average of approximately 5 years to a matter of weeks. A big thank you to the people who made the programme such a valuable experience: •⁠ ⁠Gbite Oduneye (OBDA), Yee Mun T. (Angel Academe) and Sunaina D. (Eka Ventures), the judging panel, for believing in our mission •⁠ ⁠Alan Newton our personal coach throughout the programme •⁠ ⁠Alex Sheller and Morgan Killick for their advice and support •⁠ ⁠Shantanu Baruva, Federico Piccinini, and Georgina Burton for organising and running the programme •⁠ ⁠Capital Enterprise, OneTech group, and Foundervine for delivering the programme And to the other founders in the cohort, it’s been great building alongside you over the past six months. Seeing the work everyone is doing has been genuinely motivating. Programmes like this remind you how many smart, mission-driven people are working to solve important problems. If you’re working in ophthalmology, genomics, rare disease, or drug development, feel free to reach out, always happy to chat or grab a coffee ☕ Nikolas Pontikos Ismail Moghul William Woof Elis Yalman Mengyao Xin Dhanyata Narendra #Amplify #HealthTech #AI #Genomics #Ophthalmology #Startups #RareDisease #aws #innovation